Innovations In Clinical Neuroscience

CNS Summit 2016

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: http://innovationscns.epubxp.com/i/808251

Contents of this Issue

Navigation

Page 22 of 23

[ V O L U M E 1 4 , N U M B E R 1 – 2 , J A N U A R Y – F E B R U A R Y 2 0 1 7 , S U P P L E M E N T ] Innovations in CLINICAL NEUROSCIENCE S23 BY POSTER An electronic (eCOA)-prompted Yale Global Tic Severity Scale (YGTSS) with blinded internal scoring............S7,15 Are there reporting differences at screening on the Montgomery-sberg Depression Rating Scale (MADRS) between older and younger adults when using remote assessments?............................................................... S13 [The] AtEase study: treatment of military-related PTSD............................................................................. S10 [The] clinical development of ITI-007 for the treatment of schizophrenia................................................................ S10 Clinical trial of Clickotine ® , a digital therapeutics™ solution for smoking cessation: design and total health execution methodology.............................................................. S8,12 Comparison of actigraphy endpoints for estimating nocturnal scratching duration in patients with atopic dermatitis.........................................................................S5 Could a paradigm shift in consumptive disorders research benefit patients and sponsors alike? A smoking cessation case study reinforces "the manner in which we look at things determines what we see!".................................S19 Cultural adaptation of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) for use in the United Kingdom and Canada........................................ S13 D3: deuterium drug development ............................... S11 Development of neurophysiological-based biomarkers for neurodegenerative disease and psychiatric disorders using EEG................................................................S6,9,14 Discrepancies between CGI-S score and PANSS item level scores—an exploratory analysis.................... S14,19 Drug repositioning for neurological disorders using a sustained-release formulation of exenatide.............. S11 [The] effect of cholesterol on positive symptoms of schizophrenia................................................................ S11 [The] electronic self-report of the C-SSRS (eC-SSRS) places little burden on patients initially and even less with repeated administrations........................................... S7,15 Evaluating the use of an artificial intelligence platform on mobile devices to measure adherence in subjects with an acute exacerbation of schizophrenia............S5,9,12,15,19 Factors associated with response rate in inpatient schizophrenic participants............................................ S17 Methodology and management of clinical trials with adaptive designs........................................................... S20 [The] NetSCID: a validated web-based adaptive version of the SCID that improves diagnostic accuracy in mental health research...........................................................S8,16 NetraMark: predicting placebo and drug response for pharma..........................................................S5,6,15,18,20 Optimizing the mobile clinical trial: data collection through a web-based platform in telemedicine protocol......S10,13 Patients with psychiatric diagnoses indicate willingness to report suicidal ideation and behavior more honestly by self-report than in face-to-face interviews................... S17 Sleep staging based on a reduced montage using two EOG channels.................................................................. S7 Toward a better understanding of informant contributions to schizophrenia trial quality: data from the encenicline cognitive impairment program..................................... S21 Translation of the National Institutes of Health Stroke Scale (NIHSS) list of words: methodology and challenges..................................................................... S17 Understanding rater preferences in services used to increase the reliability of clinical trials: a multi-national survey.................................................................. S18,21

Articles in this issue

Archives of this issue

view archives of Innovations In Clinical Neuroscience - CNS Summit 2016